Regardless of what position Dr.T is in, I would like each and everyone in RAC team, work towards bringing Bisantrene to the clinic as soon as possible. The By-product will be - shareholders will be looked after when that happens. Given the recent episode, and the shattering of the company value, I am hopeful, everyone involved has learned their lessons, the hard way. When Dr. T says- “ I work for shareholder value creation”, I trust him. He genuinely means it. He is the largest shareholder, after all. Dr.T, Now is the time to get the best out of Bisantrene, by uniting everyone, for both the the patients and for us, who have supported the company for so long. onwards and onwards.
RAC Price at posting:
81.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)